ERSO

N/A

Report date: 2022/04/26 15:47:43
NME

Base Information

Drug NameERSO
Drug Alias NameErSO
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor alpha agonistsApoptosis stimulants
TargetsEstrogen receptor alpha
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois At Urbana–Champaign
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Illinois At Urbana–Champaign
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A